Examples of using Flecainide in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
III antiarrhythmics(such as flecainide, propafenone, quinidine,
Medicines used to treat change s in he art rate(flecainide and propafenone); a medicine used to treat high blood pre ssure metoprolol.
Telzir with ritonavir must not be co-administered with medicinal products with narrow therapeutic windows that are highly dependent on CYP2D6 metabolism e.g. flecainide and propafenone see section 4.5.
propafenone or flecainide(medicines for abnormal heart rhythm),
which have narrow therapeutic margins e. g. flecainide, propafenone, metoprolol.
Amiodarone(used to treat abnormal heart beat), flecainide and propafenone(heart medicines), rifampicin(used to prevent or treat tuberculosis),
e. g. flecainide and propafenone see section 4.5.
such as warfarin and phenytoin(CYP2C9) and flecainide CYP2D6.
disopyramide, flecainide, lidocaine, mexiletine,
Disopyramide, flecainide, mexiletine, propafenone,
propafenone, flecainide, codeine, oxycodone
on CYP2D6 for clearance, such as the antiarrhythmics flecainide, propafenone and metoprolol given in heart failure see section 4.5.
Type 1C antiarrhythmics(e.g., flecainide, propafenone) and tricyclic antidepressants e.g., imipramine, desipramine.
on CYP2D6 for clearance, such as the antiarrhythmics flecainide, propafenone and metoprolol given in heart failure, is contraindicated see section 4.3.
certain Type 1c antiarrhythmics(e. g. propafenone and flecainide) and metoprolol.
on CYP2D6 for clearance, such as the antiarrhythmics flecainide, propafenone and metoprolol given in heart failure, is contraindicated see section 4.5.
administered with individua lly titrated, narrow therapeutic index substances that are predominantly metabolised by CYP2D6(e.g. flecainide, propafenone, metoprolol,
administered with individually titrated, narrow therapeutic index substances that are predominantly metabolised by CYP2D6(e.g. flecainide, propafenone, metoprolol,
Therefore the exposure to metoprolol or other CYP2D6 substrates(e.g. propafenone and flecainide or, to a lesser extent,
medicinal products which are primarily metabolised by CYP2D6(such as flecainide, propafenone, metoprolol)